Identifying phronotypes in psychiatry

Frontiers in Psychiatry

Volumn 1, Issue OCT, 2010, Pages

  Andrew Kozel, F ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Biomarkers; Diagnosis; Disease models; Phronotype; Psychiatry

Indexed keywords

EID: 84866768284     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2010.00141     Document Type: Article

References (24)

1. The American Heritage Dictionary, 2nd Edn. (1982). Boston: Houghton Mifflin Company.
2. Arns, M., Gunkelman, J., Breteler, M., and Spronk, D. (2008). EEG phenotypes predict treatment outcome to stimulants in children with ADHD. J. Integr. Neurosci. 7, 421-438.
3. Biswal, B., Yetkin, F. Z., Haughton, V. M., and Hyde, J. S. (1995). Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn. Reson. Med. 34, 537-541.
4. Dougherty, D. D., and Rauch, S. L. (2007). Brain correlates of antidepressant treatment outcome from neuroimaging studies in depression. Psychiatr. Clin. North Am. 30, 91-103.
5. DSM-IV. (1994). Diagnostic and Statistical Manual of Mental Disorders: DSM-IV [4th] Edn. Washington, D.C.: American Psychiatric Association.
6. George, M. S., and Belmaker, R. H. (2007). Transcranial Magnetic Stimulation in Clinical Psychiatry. Washington, D.C.: American Psychiatric Publishing, Inc.
7. Gottesman, I. I., and Gould, T. D. (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 160, 636-645.
8. Hallett, M. (2007). Transcranial magnetic stimulation: a primer. Neuron 55, 187-199.
9. Hermens, D. F., Cooper, N. J., Kohn, M., Clarke, S., and Gordon, E. (2005). Predicting stimulant medication response in ADHD: evidence from an integrated profile of neuropsychological, psychophysiological and clinical factors. J. Integr. Neurosci. 4, 107-121.
10. Hyman, S. E., and Fenton, W. S. (2003). Medicine. What are the right targets for psychopharmacology? Science 299, 350-351.
11. Insel, T. R., and Wang, P. S. (2009). The STAR*D trial: revealing the need for better treatments. Psychiatr. Serv. 60, 1466-1467.
12. Iosifescu, D. V. (2008). Prediction of response to antidepressants: is quantitative EEG (QEEG) an alternative? CNS Neurosci. Ther. 14, 263-265.
13. Kozel, F. A., and Trivedi, M. H. (2008). Developing a neuropsychiatric functional brain imaging test. Neurocase 14, 54-58.
14. Leuchter, A. F., Cook, I. A., Gilmer, W. S., Marangell, L. B., Burgoyne, K. S., Howland, R. H., Trivedi, M. H., Zisook, S., Jain, R., Fava, M., Iosifescu, D., and Greenwald, S. (2009a). Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res. 169, 132-138.
15. Leuchter, A. F., Cook, I. A., Marangell, L. B., Gilmer, W. S., Burgoyne, K. S., Howland, R. H., Trivedi, M. H., Zisook, S., Jain, R., McCracken, J. T., Fava, M., Iosifescu, D., and Greenwald, S. (2009b). Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Res. 169, 124-131.
16. Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S., Davis, S. M., Davis, C. E., Lebowitz, B. D., Severe, J., and Hsiao, J. K. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 353, 1209-1223.
17. Mayberg, H. S. (2003). Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br. Med. Bull. 65, 193-207.
18. Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., and Monteggia, L. M. (20002). Neurobiology of depression. Neuron 34, 13-25.
19. Perlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H., Wisniewski, S. R., Ketter, T. A., Miklowitz, D. J., Otto, M. W., Gyulai, L., Reilly-Harrington, N. A., Nierenberg, A. A., Sachs, G. S., and Thase, M. E. (2006). Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am. J. Psychiatry 163, 217-224.
20. Phillips, M. L., Travis, M. J., Fagiolini, A., and Kupfer, D. J. (2008). Medication effects in neuroimaging studies of bipolar disorder. Am. J. Psychiatry 165, 313-320.
21. Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., McGrath, P. J., Rosenbaum, J. F., Sackeim, H. A., Kupfer, D. J., Luther, J., and Fava, M. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 163, 1905-1917.
22. Sangal, R. B., and Sangal, J. M. (2006). Attention-deficit/hyperactivity disorder: use of cognitive evoked potential (P300) to predict treatment response. Clin. Neurophysiol. 117, 1996-2006.
23. Savitz, J., and Drevets, W. C. (2009). Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci. Biobehav. Rev. 33, 699-771.
24. Smith, D. F., and Jakobsen, S. (2009). Molecular tools for assessing human depression by positron emission tomography. Eur. Neuropsychopharmacol. 19, 611-628.